Related Experiment Video
Updated: Jul 16, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Predictors of periprocedural creatine kinase-myocardial band elevation complicating elective percutaneous coronary
Qiangjun Cai1, Kimberly A Skelding, Arthur T Armstrong
1Department of Internal Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA.
Insights
Predictors of creatine kinase-MB (CK-MB) increase after percutaneous coronary intervention (PCI) were identified. Chest pain at the procedure
Area of Science:
- Cardiology
- Interventional Cardiology
- Biomarkers
Background:
- Limited data exist on predictors of periprocedural creatine kinase-MB (CK-MB) increase post-elective percutaneous coronary intervention (PCI) in the stenting era.
- Understanding these predictors is crucial for risk stratification and patient management.
Purpose of the Study:
- To explore the predictors of periprocedural CK-MB increase following elective PCI.
- To identify factors associated with minor and major CK-MB elevations after PCI.
Main Methods:
- Retrospective analysis of 882 patients with normal preprocedural CK-MB undergoing 919 elective PCIs.
- Patients categorized into normal, minor (1-3x normal), and major (>3x normal) peak CK-MB groups.
- Logistic regression analysis to identify independent predictors for CK-MB increase.
Main Results:
- Independent predictors for minor CK-MB increase included thrombus, number of lesions, balloon size, type C lesion, chest pain during procedure, dissection, and side branch occlusion.
- Independent predictors for major CK-MB increase included chest pain at end of procedure, type C lesion, severe angina, thrombus, and abrupt closure.
- Chest pain at the end of the procedure was the strongest predictor for major CK-MB increase.
Conclusions:
- Baseline clinical and angiographic characteristics, along with procedural complications, are associated with periprocedural CK-MB increases after PCI.
- Patients experiencing chest pain at the end of the procedure face the highest risk of major CK-MB elevation.
- These findings aid in identifying high-risk patients and optimizing PCI strategies.
Abstract:
Limited data are available regarding the predictors of periprocedural creatine kinase-MB (CK-MB) isoenzyme increase after elective percutaneous coronary intervention (PCI) in the stenting era. We explored the predictors of periprocedural CK-MB increase in 882 consecutive patients with normal preprocedural CK-MB who underwent 919 angiographically successful elective PCIs with (n = 814) or without (n = 105) stenting. Patients were categorized into 3 groups based on their peak CK-MB levels after PCI: (1) normal CK-MB (n = 761), (2) minor CK-MB increase (CK-MB 1 to 3 times normal, n = 112), and (3) major CK-MB increase (CK-MB >3 times normal, n = 46). By logistic regression analysis, independent predictors for minor CK-MB increase included thrombus (odds ratio [OR] 5.09, p = 0.001), platelet IIb/IIIa antagonist use (OR 0.53, p <0.01), number of lesions treated (per additional lesion, OR 1.54, p <0.01), maximum balloon size (per millimeter increase, OR 1.57, p <0.05), American College of Cardiology/American Heart Association type C lesion (OR 1.68, p <0.05), sustained chest pain during procedure (OR 1.94, p <0.05), dissection (OR 2.05, p <0.05), and transient side branch occlusion (OR 4.54, p <0.05). Independent predictors for major CK-MB increase were chest pain at end of procedure (OR 9.66, p <0.001), type C lesion (OR 2.42, p <0.05), Canadian Cardiovascular Society angina class III to IV (OR 3.32, p <0.05), thrombus (OR 5.09, p = 0.001), and abrupt closure (OR 5.30, p <0.05). In conclusion, baseline clinical and angiographic characteristics and procedural complications were associated with minor and major CK-MB increases. Patients with chest pain at the end of the procedure were at the highest risk for major CK-MB increase.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Cardiac Catheterization IV: Nursing Management
